BioCentury
ARTICLE | Clinical News

Lidakol: Completed treatment portion of three Phase III trials

January 2, 1996 8:00 AM UTC

LIDAK Pharmaceuticals Inc. (LDAKA), La Jolla, Calif. Product: Lidakol, 10 percent n-docosanol cream Indication: Oral herpes Status: Completed treatment portion of three Phase III trials in 1,200 patie...